dystrophy
Morrée, A. de
Citation
Morrée, A. de. (2011, January 12). Functional protein networks unifying limb girdle muscular dystrophy. Retrieved from https://hdl.handle.net/1887/16329
Version: Corrected Publisher’s Version
License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/16329
Note: To cite this publication please use the final published version (if
applicable).
1. Abascal F, Zardoya R, Posada D (2005) ProtTest: selection of best-fit models of protein evolution. Bioinformatics 21: 2104- 2105. bti263 [pii];10.1093/bioinformatics/
bti263 [doi].
2. Albrecht DE, Garg N, Rufibach LE, Williams BA, Monnier N, Hwang E, Mittal P (2009) 3rd Annual Dysferlin Conference 2-5 June 2009, Boston, Massachusetts, USA. Neuromuscul Disord 19: 867-873.
S0960-8966(09)00585-9 [pii];10.1016/j.
nmd.2009.08.005 [doi].
3. Alli AA, Gower WR, Jr. (2009) The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid-induced calcium mobilization. Am J Physiol Cell Physiol 297:
C1157-C1167. 00219.2009 [pii];10.1152/
ajpcell.00219.2009 [doi].
4. Alvarez J, Hamplova J, Hohaus A, Morano I, Haase H, Vassort G (2004) Calcium current in rat cardiomyocytes is modulated by the carboxyl-terminal AHNAK domain. J Biol Chem 279: 12456-12461. 10.1074/jbc.
M312177200 [doi];M312177200 [pii].
5. Amagai M (2004) A mystery of AHNAK/desmoyokin still goes on. J Invest Dermatol 123: xiv-xxv. 10.1111/j.0022-
202X.2004.23432.x [doi];JID23432 [pii].
6. Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, Johnson MA, Bashir R, Britton S, Keers S, Argov Z, Mahjneh I, Fougerousse F, Beckmann JS, Bushby KM (1999) Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 8:
855-861. ddc087 [pii].
7. Anderson LV, Harrison RM, Pogue R, Vafiadaki E, Pollitt C, Davison K, Moss JA, Keers S, Pyle A, Shaw PJ, Mahjneh I, Argov Z, Greenberg CR, Wrogemann K, Bertorini T, Goebel HH, Beckmann JS, Bashir R, Bushby KM (2000) Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary Dysferlinopathies).
Neuromuscul Disord 10: 553-559.
S0960896600001437 [pii].
8. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:
195-201.
9. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes
recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:
1057-1069. jem.20070075 [pii];10.1084/
jem.20070075 [doi].
10. Azakir BA, di Fulvio S, Therrien C, Sinnreich M (2010) Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. PLoS One 5: e10122. 10.1371/
journal.pone.0010122 [doi].
11. Baghdiguian S, Richard I, Martin M, Coopman P, Beckmann JS, Mangeat P, Lefranc G (2001) Pathophysiology of limb girdle muscular dystrophy type 2A:
hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. J Mol Med 79: 254-261.
12. Bansal D, Campbell KP (2004) Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 14: 206-213. 10.1016/j.tcb.2004.03.001 [doi];S0962892404000546 [pii].
13. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP (2003) Defective membrane repair in Dysferlin-deficient muscular dystrophy. Nature 423: 168-172. 10.1038/
nature01573 [doi];nature01573 [pii].
14. Bartoli M, Roudaut C, Martin S, Fougerousse F, Suel L, Poupiot J, Gicquel E, Noulet F, Danos O, Richard I (2006) Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb- girdle muscular dystrophy type 2A. Mol Ther 13: 250-259. S1525-0016(05)01645-X [pii];10.1016/j.ymthe.2005.09.017 [doi].
15. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand S, Bourg N, Argov Z, Sadeh M,
Mahjneh I, Marconi G, Passos-Bueno MR, Moreira ES, Zatz M, Beckmann JS, Bushby K (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 20: 37-42. 10.1038/1689 [doi].
16. Batchelor CL, Winder SJ (2006) Sparks, signals and shock absorbers:
how dystrophin loss causes muscular dystrophy. Trends Cell Biol 16: 198-205.
S0962-8924(06)00052-3 [pii];10.1016/j.
tcb.2006.02.001 [doi].
17. Beckmann JS, Spencer M (2008) Calpain 3, the “gatekeeper” of proper sarcomere assembly, turnover and maintenance. Neuromuscul Disord 18: 913-921. S0960-8966(08)00618-4 [pii];10.1016/j.nmd.2008.08.005 [doi].
18. Belanto JJ, Diaz-Perez SV, Magyar CE, Maxwell MM, Yilmaz Y, Topp K, Boso G, Jamieson CH, Cacalano NA, Jamieson CA (2010) Dexamethasone induces Dysferlin in myoblasts and enhances their myogenic differentiation. Neuromuscul Disord 20: 111-121. S0960-8966(09)00700-7 [pii];10.1016/j.nmd.2009.12.003 [doi].
19. Benaud C, Gentil BJ, Assard N, Court M, Garin J, Delphin C, Baudier J (2004) AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J Cell Biol 164: 133-144. 10.1083/jcb.200307098 [doi];jcb.200307098 [pii].
20. Bennett-Lovsey RM, Herbert AD, Sternberg MJ, Kelley LA (2008) Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre. Proteins 70: 611-625.
21. Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, Erdjument-Bromage H, Shah V, Gratton JP, McNally EM, Tempst P, Sessa WC (2007) Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. J Biol Chem 282:
30745-30753. M704798200 [pii];10.1074/
jbc.M704798200 [doi].
22. Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger T, Maerk I, Hoger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KM, Reis A (1999) Dysferlin deletion in SJL mice (SJL- Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 23: 141- 142. 10.1038/13770 [doi].
23. Blaschuk KL, Guerin C, Holland PC (1997) Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation. Dev Biol 184: 266-277. 10.1006/dbio.1997.8527 [doi];S0012-1606(97)98527-4 [pii].
24. Blystone SD, Graham IL, Lindberg FP, Brown EJ (1994) Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1. J Cell Biol 127:
1129-1137.
25. Bolduc V, Marlow G, Boycott KM, Saleki K, Inoue H, Kroon J, Itakura M, Robitaille Y, Parent L, Baas F, Mizuta K, Kamata N, Richard I, Linssen WH, Mahjneh I, de Visser M, Bashir R, Brais B (2010) Recessive mutations in the putative calcium-
activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet 86: 213-221. S0002-9297(09)00574-6 [pii];10.1016/j.ajhg.2009.12.013 [doi].
26. Borgonovo B, Cocucci E, Racchetti G, Podini P, Bachi A, Meldolesi J (2002) Regulated exocytosis: a novel, widely expressed system. Nat Cell Biol 4: 955-962.
10.1038/ncb888 [doi];ncb888 [pii].
27. Britton S, Freeman T, Vafiadaki E, Keers S, Harrison R, Bushby K, Bashir R (2000) The third human FER-1-like protein is highly similar to Dysferlin. Genomics 68: 313-321. 10.1006/geno.2000.6290 [doi];S0888-7543(00)96290-6 [pii].
28. Bushby K (2001) The limb-girdle muscular dystrophies. Eur J Paediatr Neurol 5: 213-214. S1090-3798(01)90515-X [pii];10.1053/ejpn.2001.0515 [doi].
29. Bushby K (2009) Diagnosis and management of the limb girdle muscular dystrophies. Pract Neurol 9: 314-323.
9/6/314 [pii];10.1136/jnnp.2009.193938 [doi].
30. Bushby K, Norwood F, Straub V (2007) The limb-girdle muscular dystrophies- -diagnostic strategies. Biochim Biophys Acta 1772: 238-242. S0925-4439(06)00194-3 [pii];10.1016/j.bbadis.2006.09.009 [doi].
31. Bushby KM (1994) The muscular dystrophies. Baillieres Clin Neurol 3: 407- 430.
32. Bushby KM (1999) Making sense of the limb-girdle muscular dystrophies. Brain 122 ( Pt 8): 1403-1420.
33. Cagliani R, Magri F, Toscano A, Merlini L, Fortunato F, Lamperti C, Rodolico C, Prelle A, Sironi M, Aguennouz M, Ciscato
P, Uncini A, Moggio M, Bresolin N, Comi GP (2005) Mutation finding in patients with Dysferlin deficiency and role of the Dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies. Hum Mutat 26: 283.
10.1002/humu.9364 [doi].
34. Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, Ko JK, Lin P, Thornton A, Zhao X, Pan Z, Komazaki S, Brotto M, Takeshima H, Ma J (2009) MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 11: 56-64. ncb1812 [pii];10.1038/ncb1812 [doi].
35. Cai C, Masumiya H, Weisleder N, Pan Z, Nishi M, Komazaki S, Takeshima H, Ma J (2009) MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem 284: 3314-3322. M808866200 [pii];10.1074/jbc.M808866200 [doi].
36. Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H, Ma J (2009) Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and Dysferlin. J Biol Chem 284: 15894-15902. M109.009589 [pii];10.1074/jbc.M109.009589 [doi].
37. Carillo S, Pariat M, Steff A, Jariel- Encontre I, Poulat F, Berta P, Piechaczyk M (1996) PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein. Biochem J 313 ( Pt 1): 245-251.
38. Castellano F, Chavrier P, Caron E (2001) Actin dynamics during phagocytosis. Semin Immunol 13:
347-355. 10.1006/smim.2001.0331 [doi];S1044-5323(01)90331-8 [pii].
39. Castresana J (2000) Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol
Biol Evol 17: 540-552.
40. Caswell PT, Norman JC (2006) Integrin trafficking and the control of cell migration. Traffic 7: 14-21. TRA362 [pii];10.1111/j.1600-0854.2005.00362.x [doi].
41. Caswell PT, Vadrevu S, Norman JC (2009) Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol 10: 843-853. nrm2799 [pii];10.1038/
nrm2799 [doi].
42. Cenacchi G, Fanin M, De Giorgi LB, Angelini C (2005) Ultrastructural changes in Dysferlinopathy support defective membrane repair mechanism. J Clin Pathol 58: 190-195. 58/2/190 [pii];10.1136/
jcp.2004.018978 [doi].
43. Chattopadhyay N, Wang Z, Ashman LK, Brady-Kalnay SM, Kreidberg JA (2003) alpha3beta1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion.
J Cell Biol 163: 1351-1362. 10.1083/
jcb.200306067 [doi];jcb.200306067 [pii].
44. Chen C, Chen L, Zou X, Cai P (2009) Prediction of protein secondary structure content by using the concept of Chou’s pseudo amino acid composition and support vector machine. Protein Pept Lett 16: 27-31.
45. Chiu YH, Hornsey MA, Klinge L, Jorgensen LH, Laval SH, Charlton R, Barresi R, Straub V, Lochmuller H, Bushby K (2009) Attenuated muscle regeneration is a key factor in Dysferlin-deficient muscular dystrophy. Hum Mol Genet 18: 1976-1989.
ddp121 [pii];10.1093/hmg/ddp121 [doi].
46. Chou KC (1996) Prediction of human immunodeficiency virus protease
cleavage sites in proteins. Anal Biochem 233: 1-14.
47. Chou KC, Shen HB (2007) Recent progress in protein subcellular location prediction. Anal Biochem 370: 1-16.
48. Chou KC, Shen HB (2007) Signal- CF: a subsite-coupled and window-fusing approach for predicting signal peptides.
Biochem Biophys Res Commun 357: 633- 640.
49. Chou KC, Shen HB (2008) Cell- PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms. Nat Protoc 3: 153-162.
50. Chou KC, Shen HB (2010) A new method for predicting the subcellular localization of eukaryotic proteins with both single and multiple sites: Euk-mPLoc 2.0.
PLoS One 5: e9931.
51. Chou KC, Zhang CT (1995) Prediction of protein structural classes. Crit Rev Biochem Mol Biol 30: 275-349.
52. Cocucci E, Racchetti G, Podini P, Meldolesi J (2007) Enlargeosome traffic:
exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both. Traffic 8: 742-757. TRA566 [pii];10.1111/j.1600-0854.2007.00566.x [doi].
53. Cocucci E, Racchetti G, Podini P, Rupnik M, Meldolesi J (2004) Enlargeosome, an exocytic vesicle resistant to nonionic detergents, undergoes endocytosis via a nonacidic route. Mol Biol Cell 15: 5356- 5368. E04-07-0577 [pii];10.1091/mbc.E04- 07-0577 [doi].
54. Cohen N, Kudryashova E, Kramerova I, Anderson LV, Beckmann JS, Bushby K, Spencer MJ (2006) Identification
of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice.
Proteomics 6: 6075-6084. 10.1002/
pmic.200600199 [doi].
55. Collinet C, Stoter M, Bradshaw CR, Samusik N, Rink JC, Kenski D, Habermann B, Buchholz F, Henschel R, Mueller MS, Nagel WE, Fava E, Kalaidzidis Y, Zerial M (2010) Systems survey of endocytosis by multiparametric image analysis. Nature 464: 243-249.
56. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, Partridge TA, Morgan JE (2005) Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301. S0092-8674(05)00455-1 [pii];10.1016/j.cell.2005.05.010 [doi].
57. Collins CA, Zammit PS, Ruiz AP, Morgan JE, Partridge TA (2007) A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 25: 885-894. 2006- 0372 [pii];10.1634/stemcells.2006-0372 [doi].
58. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment.
Nature 433: 760-764. nature03260 [pii];10.1038/nature03260 [doi].
59. Court FA, Brophy PJ, Ribchester RR (2008) Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice. Glia 56: 471-479.
60. Covian-Nares JF, Koushik SV, Puhl HLI, Vogel SS (2010) Membrane wounding triggers ATP release and Dysferlin-mediated intercellular calcium signaling. J Cell Sci
123: 1884-1893. jcs.066084 [pii];10.1242/
jcs.066084 [doi].
61. Cuerrier D, Moldoveanu T, Davies PL (2005) Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions. J Biol Chem 280:
40632-40641. M506870200 [pii];10.1074/
jbc.M506870200 [doi].
62. Dargelos E, Moyen C, Dedieu S, Veschambre P, Poussard S, Vuillier-Devillers K, Brustis JJ, Cottin P (2002) Development of an inducible system to assess p94 (CAPN3) function in cultured muscle cells. J Biotechnol 96: 271-279.
63. Davis DB, Delmonte AJ, Ly CT, McNally EM (2000) Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum Mol Genet 9: 217-226.
ddd030 [pii].
64. Davis DM (2009) Mechanisms and functions for the duration of intercellular contacts made by lymphocytes. Nat Rev Immunol 9: 543-555. nri2602 [pii];10.1038/
nri2602 [doi].
65. de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, Bairoch A, Hulo N (2006) ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res 34: W362-W365.
66. de Luna N, Freixas A, Gallano P, Caselles L, Rojas-Garcia R, Paradas C, Nogales G, Dominguez-Perles R, Gonzalez- Quereda L, Vilchez JJ, Marquez C, Bautista J, Guerrero A, Salazar JA, Pou A, Illa I, Gallardo E (2007) Dysferlin expression in monocytes: a source of mRNA for mutation
analysis. Neuromuscul Disord 17: 69-76.
S0960-8966(06)00538-4 [pii];10.1016/j.
nmd.2006.09.006 [doi].
67. de Luna N, Gallardo E, Illa I (2004) In vivo and in vitro Dysferlin expression in human muscle satellite cells. J Neuropathol Exp Neurol 63: 1104-1113.
68. de Luna N, Gallardo E, Sonnet C, Chazaud B, Dominguez-Perles R, Suarez- Calvet X, Gherardi RK, Illa I (2010) Role of thrombospondin 1 in macrophage inflammation in Dysferlin myopathy. J Neuropathol Exp Neurol 69: 643-653.
10.1097/NEN.0b013e3181e0d01c [doi].
69. de Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, Rojas- Garcia R, Garcia-Verdugo JM, Illa I (2006) Absence of Dysferlin alters myogenin expression and delays human muscle differentiation “in vitro”. J Biol Chem 281:
17092-17098. M601885200 [pii];10.1074/
jbc.M601885200 [doi].
70. de Palma S, Morandi L, Mariani E, Begum S, Cerretelli P, Wait R, Gelfi C (2006) Proteomic investigation of the molecular pathophysiology of Dysferlinopathy.
Proteomics 6: 379-385. 10.1002/
pmic.200500098 [doi].
71. de Seranno S, Benaud C, Assard N, Khediri S, Gerke V, Baudier J, Delphin C (2006) Identification of an AHNAK binding motif specific for the Annexin2/
S100A10 tetramer. J Biol Chem 281: 35030- 35038. M606545200 [pii];10.1074/jbc.
M606545200 [doi].
72. Diaz BG, Moldoveanu T, Kuiper MJ, Campbell RL, Davies PL (2004) Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide. J Biol
Chem 279: 27656-27666. 10.1074/jbc.
M313290200 [doi];M313290200 [pii].
73. Dincer P, Leturcq F, Richard I, Piccolo F, Yalnizoglu D, de TC, Akcoren Z, Broux O, Deburgrave N, Brenguier L, Roudaut C, Urtizberea JA, Jung D, Tan E, Jeanpierre M, Campbell KP, Kaplan JC, Beckmann JS, Topaloglu H (1997) A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 42: 222- 229. 10.1002/ana.410420214 [doi].
74. Disatnik MH, Rando TA (1999) Integrin-mediated muscle cell spreading.
The role of protein kinase c in outside-in and inside-out signaling and evidence of integrin cross-talk. J Biol Chem 274: 32486-32492.
75. Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, Earley JU, Hadhazy M, McNally EM (2005) Normal myoblast fusion requires Myoferlin. Development 132: 5565-5575. dev.02155 [pii];10.1242/
dev.02155 [doi].
76. Doherty KR, Demonbreun AR, Wallace GQ, Cave A, Posey AD, Heretis K, Pytel P, McNally EM (2008) The endocytic recycling protein EHD2 interacts with Myoferlin to regulate myoblast fusion. J Biol Chem 283: 20252-20260. M802306200 [pii];10.1074/jbc.M802306200 [doi].
77. Duguez S, Bartoli M, Richard I (2006) Calpain 3: a key regulator of the sarcomere? FEBS J 273: 3427- 3436. EJB5351 [pii];10.1111/j.1742- 4658.2006.05351.x [doi].
78. Dupuy AG, Caron E (2008) Integrin-dependent phagocytosis: spreading from microadhesion to new concepts. J Cell Sci 121: 1773-1783. 121/11/1773
[pii];10.1242/jcs.018036 [doi].
79. Dytrych L, Sherman DL, Gillespie CS, Brophy PJ (1998) Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells.
J Biol Chem 273: 5794-5800.
80. Fanin M, Fulizio L, Nascimbeni AC, Spinazzi M, Piluso G, Ventriglia VM, Ruzza G, Siciliano G, Trevisan CP, Politano L, Nigro V, Angelini C (2004) Molecular diagnosis in LGMD2A: mutation analysis or protein testing? Hum Mutat 24: 52-62.
81. Foxton RM, Laval SH, Bushby KM (2004) Characterisation of the Dysferlin skeletal muscle promoter. Eur J Hum Genet 12: 127-131. 10.1038/sj.ejhg.5201092 [doi];5201092 [pii].
82. Frosk P, Weiler T, Nylen E, Sudha T, Greenberg CR, Morgan K, Fujiwara TM, Wrogemann K (2002) Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 70: 663-672.
83. Fujita E, Kouroku Y, Isoai A, Kumagai H, Misutani A, Matsuda C, Hayashi YK, Momoi T (2007) Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant Dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II). Hum Mol Genet 16: 618-629. ddm002 [pii];10.1093/
hmg/ddm002 [doi].
84. Gagne D, Groulx JF, Benoit YD, Basora N, Herring E, Vachon PH, Beaulieu JF (2010) Integrin-linked kinase regulates migration and proliferation of human intestinal cells under a fibronectin- dependent mechanism. J Cell Physiol 222:
387-400. 10.1002/jcp.21963 [doi].
85. Galbiati F, Razani B, Lisanti MP (2001) Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 7: 435-441.
S1471-4914(01)02105-0 [pii].
86. Gallardo E, Rojas-Garcia R, De Luna N, Pou A, Brown RH, Jr., Illa I (2001) Inflammation in Dysferlin myopathy:
immunohistochemical characterization of 13 patients. Neurology 57: 2136-2138.
87. Garnham CP, Hanna RA, Chou JS, Low KE, Gourlay K, Campbell RL, Beckmann JS, Davies PL (2009) Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3. Biochemistry 48: 3457- 3467. 10.1021/bi900130u [doi];10.1021/
bi900130u [pii].
88. Geiss-Friedlander R, Melchior F (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956.
nrm2293 [pii];10.1038/nrm2293 [doi].
89. Gentil BJ, Benaud C, Delphin C, Remy C, Berezowski V, Cecchelli R, Feraud O, Vittet D, Baudier J (2005) Specific AHNAK expression in brain endothelial cells with barrier properties. J Cell Physiol 203: 362- 371. 10.1002/jcp.20232 [doi].
90. Gentil BJ, Delphin C, Benaud C, Baudier J (2003) Expression of the giant protein AHNAK (desmoyokin) in muscle and lining epithelial cells. J Histochem Cytochem 51: 339-348.
91. Gentil BJ, Delphin C, Mbele GO, Deloulme JC, Ferro M, Garin J, Baudier J (2001) The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B. J
Biol Chem 276: 23253-23261. 10.1074/jbc.
M010655200 [doi];M010655200 [pii].
92. Gillespie CS, Sherman DL, Blair GE, Brophy PJ (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12:
497-508.
93. Glover LE, Newton K, Krishnan G, Bronson R, Boyle A, Krivickas LS, Brown RH, Jr. (2010) Dysferlin overexpression in skeletal muscle produces a progressive myopathy. Ann Neurol 67: 384-393.
10.1002/ana.21926 [doi].
94. Gottlieb A, Krueger JG, Bright R, Ling M, Lebwohl M, Kang S, Feldman S, Spellman M, Wittkowski K, Ochs HD, Jardieu P, Bauer R, White M, Dedrick R, Garovoy M (2000) Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 42: 428-435.
S0190-9622(00)90214-7 [pii].
95. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
54QHX07WB5K5XCX4 [pii].
96. Guindon S, Lethiec F, Duroux P, Gascuel O (2005) PHYML Online--a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 33: W557-W559. 33/suppl_2/W557 [pii];10.1093/nar/gki352 [doi].
97. Gutierrez GJ, Ronai Z (2006) Ubiquitin and SUMO systems in the regulation of mitotic checkpoints. Trends Biochem Sci 31: 324-332. S0968-0004(06)00095-8 [pii];10.1016/j.tibs.2006.04.001 [doi].
98. Guyon JR, Kudryashova E, Potts
A, Dalkilic I, Brosius MA, Thompson TG, Beckmann JS, Kunkel LM, Spencer MJ (2003) Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta- sarcoglycans. Muscle Nerve 28: 472-483.
10.1002/mus.10465 [doi].
99. Haase H (2007) AHNAK, a new player in beta-adrenergic regulation of the cardiac L-type Ca2+ channel. Cardiovasc Res 73: 19-25. S0008-6363(06)00400- 7 [pii];10.1016/j.cardiores.2006.09.001 [doi].
100. Haase H, Alvarez J, Petzhold D, Doller A, Behlke J, Erdmann J, Hetzer R, Regitz-Zagrosek V, Vassort G, Morano I (2005) AHNAK is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation. FASEB J 19:
1969-1977. 19/14/1969 [pii];10.1096/
fj.05-3997com [doi].
101. Haase H, Pagel I, Khalina Y, Zacharzowsky U, Person V, Lutsch G, Petzhold D, Kott M, Schaper J, Morano I (2004) The carboxyl-terminal AHNAK domain induces actin bundling and stabilizes muscle contraction. FASEB J 18: 839-841.
10.1096/fj.03-0446fje [doi];03-0446fje [pii].
102. Haase H, Podzuweit T, Lutsch G, Hohaus A, Kostka S, Lindschau C, Kott M, Kraft R, Morano I (1999) Signaling from beta- adrenoceptor to L-type calcium channel:
identification of a novel cardiac protein kinase A target possessing similarities to AHNAK. FASEB J 13: 2161-2172.
103. Haller K, Rambaldi I, Daniels E, Featherstone M (2004) Subcellular localization of multiple PREP2 isoforms is regulated by actin, tubulin, and
nuclear export. J Biol Chem 279: 49384- 49394. 10.1074/jbc.M406046200 [doi];M406046200 [pii].
104. Haravuori H, Vihola A, Straub V, Auranen M, Richard I, Marchand S, Voit T, Labeit S, Somer H, Peltonen L, Beckmann JS, Udd B (2001) Secondary calpain3 deficiency in 2q-linked muscular dystrophy:
titin is the candidate gene. Neurology 56:
869-877.
105. Hashimoto T, Amagai M, Parry DA, Dixon TW, Tsukita S, Tsukita S, Miki K, Sakai K, Inokuchi Y, Kudoh J, . (1993) Desmoyokin, a 680 kDa keratinocyte plasma membrane- associated protein, is homologous to the protein encoded by human gene AHNAK. J Cell Sci 105 ( Pt 2): 275-286.
106. Hashimoto T, Gamou S, Shimizu N, Kitajima Y, Nishikawa T (1995) Regulation of translocation of the desmoyokin/
AHNAK protein to the plasma membrane in keratinocytes by protein kinase C. Exp Cell Res 217: 258-266. S0014-4827(85)71085- 3 [pii];10.1006/excr.1995.1085 [doi].
107. Hayashi C, Ono Y, Doi N, Kitamura F,-tagami M, Mineki R, Arai T,-taguchi H, Yanagida M, Hirner S, Labeit D, Labeit S, Sorimachi H (2008) Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle. J Biol Chem 283: 14801-14814. M708262200 [pii];10.1074/jbc.M708262200 [doi].
108. Hayashi YK, Chou FL, Engvall E, Ogawa M, Matsuda C, Hirabayashi S, Yokochi K, Ziober BL, Kramer RH, Kaufman SJ, Ozawa E, Goto Y, Nonaka I, Tsukahara T, Wang JZ, Hoffman EP, Arahata K (1998) Mutations in the integrin alpha7 gene cause
congenital myopathy. Nat Genet 19: 94-97.
109. Haynes C, Oldfield CJ, Ji F, Klitgord N, Cusick ME, Radivojac P, Uversky VN, Vidal M, Iakoucheva LM (2006) Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput Biol 2: e100. 06-PLCB-RA-0152R2 [pii];10.1371/journal.pcbi.0020100 [doi].
110. Hernandez-Deviez DJ, Howes MT, Laval SH, Bushby K, Hancock JF, Parton RG (2008) Caveolin regulates endocytosis of the muscle repair protein, Dysferlin. J Biol Chem 283: 6476-6488. M708776200 [pii];10.1074/jbc.M708776200 [doi].
111. Hernandez-Deviez DJ, Martin S, Laval SH, Lo HP, Cooper ST, North KN, Bushby K, Parton RG (2006) Aberrant Dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum Mol Genet 15: 129-142.
ddi434 [pii];10.1093/hmg/ddi434 [doi].
112. Hestand MS, Klingenhoff A, Scherf M, Ariyurek Y, Ramos Y, van Workum W, Suzuki M, Werner T, van Ommen GJ, den Dunnen JT, Harbers M, ‘t Hoen PA (2010) Tissue-specific transcript annotation and expression profiling with complementary next-generation sequencing technologies.
Nucleic Acids Res . gkq602 [pii];10.1093/
nar/gkq602 [doi].
113. Hieda Y, Tsukita S, Tsukita S (1989) A new high molecular mass protein showing unique localization in desmosomal plaque. J Cell Biol 109: 1511-1518.
114. Ho M, Gallardo E, McKenna-Yasek D, de Luna N, Illa I, Brown Jr RH (2002) A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Ann Neurol 51: 129-133.
10.1002/ana.10080 [pii].
115. Hoffman EP, Brown RH, Jr., Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus.
Cell 51: 919-928. 0092-8674(87)90579-4 [pii].
116. Hofmann WA, Arduini A, Nicol SM, Camacho CJ, Lessard JL, Fuller-Pace FV, de Lanerolle P (2009) SUMOylation of nuclear actin. J Cell Biol 186: 193- 200. jcb.200905016 [pii];10.1083/
jcb.200905016 [doi].
117. Hohaus A, Person V, Behlke J, Schaper J, Morano I, Haase H (2002) The carboxyl-terminal region of AHNAK provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J 16: 1205-1216. 10.1096/fj.01-0855com [doi];16/10/1205 [pii].
118. Huang Y, de Morree A, van Remoortere A, Bushby K, Frants RR, den Dunnen JT, van der Maarel SM (2008) Calpain 3 is a modulator of the Dysferlin protein complex in skeletal muscle. Hum Mol Genet 17: 1855-1866. ddn081 [pii];10.1093/hmg/
ddn081 [doi].
119. Huang Y, Laval SH, van Remoortere A, Baudier J, Benaud C, Anderson LV, Straub V, Deelder A, Frants RR, den Dunnen JT, Bushby K, van der Maarel SM (2007) AHNAK, a novel component of the Dysferlin protein complex, redistributes to the cytoplasm with Dysferlin during skeletal muscle regeneration. FASEB J 21: 732-742. fj.06- 6628com [pii];10.1096/fj.06-6628com [doi].
120. Huang Y, Verheesen P, Roussis A, Frankhuizen W, Ginjaar I, Haldane F, Laval S, Anderson LV, Verrips T, Frants RR, de Haard
H, Bushby K, den Dunnen JT, van der Maarel SM (2005) Protein studies in Dysferlinopathy patients using llama-derived antibody fragments selected by phage display.
Eur J Hum Genet 13: 721-730. 5201414 [pii];10.1038/sj.ejhg.5201414 [doi].
121. Hubbard SJ (1998) The structural aspects of limited proteolysis of native proteins. Biochim Biophys Acta 1382: 191- 206.
122. Huebsch KA, Kudryashova E, Wooley CM, Sher RB, Seburn KL, Spencer MJ, Cox GA (2005) Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin’s N2A domain.
Hum Mol Genet 14: 2801-2811. ddi313 [pii];10.1093/hmg/ddi313 [doi].
123. Huelsenbeck JP, Ronquist F (2001) MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17: 754- 755.
124. Hulo N, Bairoch A, Bulliard V, Cerutti L, de Castro E, Langendijk-Genevaux PS, Pagni M, Sigrist CJ (2006) The PROSITE database. Nucleic Acids Res 34: D227-D230.
125. Hynes RO (2002) Integrins:
bidirectional, allosteric signaling machines.
Cell 110: 673-687. S0092867402009716 [pii].
126. Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-Garcia R, Palmer J, Gallano P, Baiget M, Matsuda C, Brown RH (2001) Distal anterior compartment myopathy: a Dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 49: 130- 134.
127. Imhof BA, Aurrand-Lions M (2004) Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol
4: 432-444. 10.1038/nri1375 [doi];nri1375 [pii].
128. Imhof BA, Weerasinghe D, Brown EJ, Lindberg FP, Hammel P, Piali L, Dessing M, Gisler R (1997) Cross talk between alpha(v)beta3 and alpha4beta1 integrins regulates lymphocyte migration on vascular cell adhesion molecule 1. Eur J Immunol 27:
3242-3252. 10.1002/eji.1830271223 [doi].
129. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272. M500061- MCP200 [pii];10.1074/mcp.M500061- MCP200 [doi].
130. Izzedine H, Brocheriou I, Eymard B, Le Charpentier M, Romero NB, Lenaour G, Bourry E, Deray G (2006) Loss of podocyte Dysferlin expression is associated with minimal change nephropathy. Am J Kidney Dis 48: 143-150. S0272-6386(06)00766-9 [pii];10.1053/j.ajkd.2006.04.074 [doi].
131. Jackson DY (2002) Alpha 4 integrin antagonists. Curr Pharm Des 8: 1229-1253.
132. Jang HD, Yoon K, Shin YJ, Kim J, Lee SY (2004) PIAS3 suppresses NF-kappaB- mediated transcription by interacting with the p65/RelA subunit. J Biol Chem 279:
24873-24880.
133. Jelier R, Schuemie MJ, Roes PJ, van Mulligen EM, Kors JA (2008) Literature- based concept profiles for gene annotation:
the issue of weighting. Int J Med Inform 77:
354-362.
134. Jelier R, Schuemie MJ, Veldhoven A, Dorssers LC, Jenster G, Kors JA (2008)
Anni 2.0: a multipurpose text-mining tool for the life sciences. Genome Biol 9: R96.
135. Jia Z, Petrounevitch V, Wong A, Moldoveanu T, Davies PL, Elce JS, Beckmann JS (2001) Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain. Biophys J 80: 2590-2596.
S0006-3495(01)76229-7 [pii];10.1016/
S0006-3495(01)76229-7 [doi].
136. Jones DT (1999) Protein secondary structure prediction based on position- specific scoring matrices. J Mol Biol 292:
195-202.
137. Kijima K, Numakura C, Shirahata E, Sawaishi Y, Shimohata M, Igarashi S, Tanaka T, Hayasaka K (2004) Periaxin mutation causes early-onset but slow-progressive Charcot-Marie-Tooth disease. J Hum Genet 49: 376-379.
138. Kinbara K, Ishiura S, Tomioka S, Sorimachi H, Jeong SY, Amano S, Kawasaki H, Kolmerer B, Kimura S, Labeit S, Suzuki K (1998) Purification of native p94, a muscle- specific calpain, and characterization of its autolysis. Biochem J 335 ( Pt 3): 589-596.
139. Kinbara K, Sorimachi H, Ishiura S, Suzuki K (1998) Skeletal muscle-specific calpain, p49: structure and physiological function. Biochem Pharmacol 56: 415-420.
S0006295298000951 [pii].
140. Kingsley PD, McGrath KE, Maltby KM, Koniski AD, Ramchandran R, Palis J (2001) Subtractive hybridization reveals tissue-specific expression of AHNAK during embryonic development. Dev Growth Differ 43: 133-143. dgd557 [pii].
141. Kitzmann M, Vandromme M, Schaeffer V, Carnac G, Labbe JC, Lamb
N, Fernandez A (1999) cdk1- and cdk2- mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol Cell Biol 19: 3167-3176.
142. Klinge L, Harris J, Sewry C, Charlton R, Anderson L, Laval S, Chiu YH, Hornsey M, Straub V, Barresi R, Lochmuller H, Bushby K (2010) Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle. Muscle Nerve 41:
166-173. 10.1002/mus.21166 [doi].
143. Klinge L, Laval S, Keers S, Haldane F, Straub V, Barresi R, Bushby K (2007) From T-tubule to sarcolemma: damage-induced Dysferlin translocation in early myogenesis.
FASEB J 21: 1768-1776. fj.06-7659com [pii];10.1096/fj.06-7659com [doi].
144. Klooster R, Eman MR, le Duc Q, Verheesen P, Verrips CT, Roovers RC, Post JA (2009) Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression. J Immunol Methods 342: 1-12. S0022-1759(08)00314-1 [pii];10.1016/j.jim.2008.10.009 [doi].
145. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45: 498-506.
146. Komuro A, Masuda Y, Kobayashi K, Babbitt R, Gunel M, Flavell RA, Marchesi VT (2004) The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells. Proc Natl Acad Sci U S A 101:
4053-4058. 10.1073/pnas.0308619101 [doi];0308619101 [pii].
147. Kontrogianni-Konstantopoulos A, Ackermann MA, Bowman AL, Yap SV, Bloch RJ (2009) Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol Rev 89: 1217-1267. 89/4/1217 [pii];10.1152/
physrev.00017.2009 [doi].
148. Kouno M, Kondoh G, Horie K, Komazawa N, Ishii N, Takahashi Y, Takeda J, Hashimoto T (2004) AHNAK/Desmoyokin is dispensable for proliferation, differentiation, and maintenance of integrity in mouse epidermis. J Invest Dermatol 123: 700- 707. 10.1111/j.0022-202X.2004.23412.x [doi];JID23412 [pii].
149. Krahn M, Bernard R, Pecheux C, Hammouda eH, Eymard B, Lopez dM, Cobo AM, Romero N, Urtizberea A, Leturcq F, Levy N (2006) Screening of the CAPN3 gene in patients with possible LGMD2A. Clin Genet 69: 444-449.
150. Krajacic P, Hermanowski J, Lozynska O, Khurana TS, Lamitina T (2009) C. elegans Dysferlin homolog fer-1 is expressed in muscle, and fer-1 mutations initiate altered gene expression of muscle enriched genes.
Physiol Genomics 40: 8-14. 00106.2009 [pii];10.1152/physiolgenomics.00106.2009 [doi].
151. Kramerova I, Beckmann JS, Spencer MJ (2007) Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Biochim Biophys Acta 1772: 128-144. S0925-4439(06)00142-6 [pii];10.1016/j.bbadis.2006.07.002 [doi].
152. Kramerova I, Kudryashova E, Tidball JG, Spencer MJ (2004) Null mutation of calpain 3 (p94) in mice causes abnormal
sarcomere formation in vivo and in vitro.
Hum Mol Genet 13: 1373-1388. 10.1093/
hmg/ddh153 [doi];ddh153 [pii].
153. Kramerova I, Kudryashova E, Venkatraman G, Spencer MJ (2005) Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum Mol Genet 14: 2125-2134.
ddi217 [pii];10.1093/hmg/ddi217 [doi].
154. Kramerova I, Kudryashova E, Wu B, Germain S, Vandenborne K, Romain N, Haller RG, Verity MA, Spencer MJ (2009) Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle. Hum Mol Genet 18: 3194-3205. ddp257 [pii];10.1093/hmg/
ddp257 [doi].
155. Kramerova I, Kudryashova E, Wu B, Ottenheijm C, Granzier H, Spencer MJ (2008) Novel role of calpain-3 in the triad- associated protein complex regulating calcium release in skeletal muscle. Hum Mol Genet 17: 3271-3280. ddn223 [pii];10.1093/hmg/ddn223 [doi].
156. Kramerova I, Kudryashova E, Wu B, Spencer MJ (2006) Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation. Mol Cell Biol 26: 8437-8447.
MCB.01296-06 [pii];10.1128/MCB.01296- 06 [doi].
157. Krippahl L, Moura JJ, Palma PN (2003) Modeling protein complexes with BiGGER. Proteins 52: 19-23.
158. Kudoh J, Wang Y, Minoshima S, Hashimoto T, Amagai M, Nishikawa T, Shtivelman E, Bishop JM, Shimizu N (1995) Localization of the human AHNAK/
desmoyokin gene (AHNAK) to chromosome
band 11q12 by somatic cell hybrid analysis and fluorescence in situ hybridization.
Cytogenet Cell Genet 70: 218-220.
159. Lapidos KA, Kakkar R, McNally EM (2004) The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94: 1023-1031.
10.1161/01.RES.0000126574.61061.25 [doi];94/8/1023 [pii].
160. Laval SH, Bushby KM (2004) Limb- girdle muscular dystrophies--from genetics to molecular pathology. Neuropathol Appl Neurobiol 30: 91-105. 10.1111/j.1365- 2990.2004.00555.x [doi];NAN555 [pii].
161. Lebart MC, Benyamin Y (2006) Calpain involvement in the remodeling of cytoskeletal anchorage complexes. FEBS J 273: 3415-3426.
162. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH, Jr.
(2003) Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 278: 50466- 50473. 10.1074/jbc.M307247200 [doi];M307247200 [pii].
163. Li S, Kimura E, Fall BM, Reyes M, Angello JC, Welikson R, Hauschka SD, Chamberlain JS (2005) Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther 12: 1099-1108. 3302505 [pii];10.1038/
sj.gt.3302505 [doi].
164. Lin H (2008) The modified Mahalanobis Discriminant for predicting outer membrane proteins by using Chou’s pseudo amino acid composition. J Theor Biol 252: 350-356.
165. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA,
Hentati F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossie K, Oeltjen J, Bejaoui K, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de Jong PJ, Brown RH, Jr. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20:
31-36. 10.1038/1682 [doi].
166. Longo-Guess C, Gagnon LH, Bergstrom DE, Johnson KR (2007) A missense mutation in the conserved C2B domain of otoferlin causes deafness in a new mouse model of DFNB9. Hear Res 234: 21-28. S0378-5955(07)00214-6 [pii];10.1016/j.heares.2007.09.005 [doi].
167. Lorusso A, Covino C, Priori G, Bachi A, Meldolesi J, Chieregatti E (2006) Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis. EMBO J 25: 5443-5456. 7601419 [pii];10.1038/
sj.emboj.7601419 [doi].
168. Lostal W, Bartoli M, Bourg N, Roudaut C, Bentaib A, Miyake K, Guerchet N, Fougerousse F, McNeil P, Richard I (2010) Efficient recovery of Dysferlin deficiency by dual adeno-associated vector-mediated gene transfer. Hum Mol Genet 19: 1897- 1907. ddq065 [pii];10.1093/hmg/ddq065 [doi].
169. Luft FC (2007) Dysferlin, dystrophy, and dilatative cardiomyopathy. J Mol Med 85: 1157-1159. 10.1007/s00109-007- 0252-8 [doi].
170. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991) By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222: 581-597. 0022- 2836(91)90498-U [pii].
171. Matsuda C, Aoki M, Hayashi YK, Ho MF, Arahata K, Brown RH, Jr. (1999) Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy.
Neurology 53: 1119-1122.
172. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, Arahata K, Brown RH, Jr. (2001) The sarcolemmal proteins Dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 10: 1761-1766.
173. Matsuda C, Kameyama K, Suzuki A, Mishima W, Yamaji S, Okamoto H, Nishino I, Hayashi YK (2008) Affixin activates Rac1 via betaPIX in C2C12 myoblast. FEBS Lett 582: 1189-1196. S0014-5793(08)00168-3 [pii];10.1016/j.febslet.2008.01.064 [doi].
174. Matsuda C, Kameyama K,-tagawa K, Ogawa M, Suzuki A, Yamaji S, Okamoto H, Nishino I, Hayashi YK (2005) Dysferlin interacts with affixin (beta-parvin) at the sarcolemma. J Neuropathol Exp Neurol 64:
334-340.
175. Matza D, Badou A, Jha MK, Willinger T, Antov A, Sanjabi S, Kobayashi KS, Marchesi VT, Flavell RA (2009) Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc Natl Acad Sci U S A 106: 9785-9790. 0902844106 [pii];10.1073/pnas.0902844106 [doi].
176. Matza D, Badou A, Kobayashi KS, Goldsmith-Pestana K, Masuda Y, Komuro A, McMahon-Pratt D, Marchesi VT, Flavell RA (2008) A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity 28: 64-74.
S1074-7613(07)00585-7 [pii];10.1016/j.
immuni.2007.11.020 [doi].
177. Matza D, Flavell RA (2009) Roles of
Ca(v) channels and AHNAK1 in T cells: the beauty and the beast. Immunol Rev 231:
257-264. IMR805 [pii];10.1111/j.1600- 065X.2009.00805.x [doi].
178. McGuffin LJ, Bryson K, Jones DT (2000) The PSIPRED protein structure prediction server. Bioinformatics 16: 404- 405.
179. McNeil AK, Rescher U, Gerke V, McNeil PL (2006) Requirement for annexin A1 in plasma membrane repair. J Biol Chem 281: 35202-35207. M606406200 [pii];10.1074/jbc.M606406200 [doi].
180. McNeil PL, Steinhardt RA (2003) Plasma membrane disruption: repair, prevention, adaptation. Annu Rev Cell Dev Biol 19: 697-731. 10.1146/annurev.
cellbio.19.111301.140101 [doi].
181. Mellgren RL, Huang X (2007) Fetuin A stabilizes m-calpain and facilitates plasma membrane repair. J Biol Chem 282:
35868-35877. M706929200 [pii];10.1074/
jbc.M706929200 [doi].
182. Mellgren RL, Miyake K, Kramerova I, Spencer MJ, Bourg N, Bartoli M, Richard I, Greer PA, McNeil PL (2009) Calcium- dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases.
Biochim Biophys Acta 1793: 1886-1893.
S0167-4889(09)00238-9 [pii];10.1016/j.
bbamcr.2009.09.013 [doi].
183. Mellgren RL, Zhang W, Miyake K, McNeil PL (2007) Calpain is required for the rapid, calcium-dependent repair of wounded plasma membrane. J Biol Chem 282: 2567- 2575. M604560200 [pii];10.1074/jbc.
M604560200 [doi].
184. Milic A, Daniele N, Lochmuller
H, Mora M, Comi GP, Moggio M, Noulet F, Walter MC, Morandi L, Poupiot J, Roudaut C, Bittner RE, Bartoli M, Richard I (2007) A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay. Neuromuscul Disord 17: 148-156. S0960-8966(06)00613-4 [pii];10.1016/j.nmd.2006.11.001 [doi].
185. Millay DP, Maillet M, Roche JA, Sargent MA, McNally EM, Bloch RJ, Molkentin JD (2009) Genetic manipulation of Dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Am J Pathol 175: 1817-1823. ajpath.2009.090107 [pii];10.2353/ajpath.2009.090107 [doi].
186. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F (1998) Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18: 365-368. 10.1038/ng0498-365 [doi].
187. Mirghomizadeh F, Pfister M, Apaydin F, Petit C, Kupka S, Pusch CM, Zenner HP, Blin N (2002) Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness. Neurobiol Dis 10: 157- 164. S0969996102904882 [pii].
188. Moldoveanu T, Gehring K, Green DR (2008) Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 456: 404- 408.
189. Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, Jat PS, Noble MD, Farmer K, Partridge TA (1994) Myogenic cell lines derived from transgenic mice
carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol 162: 486-498.
190. Munoz P, Rosemblatt M, Testar X, Palacin M, Zorzano A (1995) Isolation and characterization of distinct domains of sarcolemma and T-tubules from rat skeletal muscle. Biochem J 307 ( Pt 1): 273-280.
191. Murphy RM, Lamb GD (2009) Endogenous calpain-3 activation is primarily governed by small increases in resting cytoplasmic [Ca2+] and is not dependent on stretch. J Biol Chem 284: 7811- 7819. M808655200 [pii];10.1074/jbc.
M808655200 [doi].
192. Muyldermans S (2001) Single domain camel antibodies: current status.
J Biotechnol 74: 277-302. S1389- 0352(01)00021-6 [pii].
193. Nagaraju K, Rawat R, Veszelovszky E, Thapliyal R, Kesari A, Sparks S, Raben N, Plotz P, Hoffman EP (2008) Dysferlin deficiency enhances monocyte phagocytosis:
a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. Am J Pathol 172: 774-785. ajpath.2008.070327 [pii];10.2353/ajpath.2008.070327 [doi].
194. Olson TM, Illenberger S, Kishimoto NY, Huttelmaier S, Keating MT, Jockusch BM (2002) Metavinculin mutations alter actin interaction in dilated cardiomyopathy.
Circulation 105: 431-437.
195. Ono Y, Kakinuma K, Torii F, Irie A, Nakagawa K, Labeit S, Abe K, Suzuki K, Sorimachi H (2004) Possible regulation of the conventional calpain system by skeletal muscle-specific calpain, p94/calpain 3. J Biol Chem 279: 2761-2771. 10.1074/jbc.
M308789200 [doi];M308789200 [pii].
196. Ono Y, Shimada H, Sorimachi H, Richard I, Saido TC, Beckmann JS, Ishiura S, Suzuki K (1998) Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 273: 17073-17078.
197. Palma PN, Krippahl L, Wampler JE, Moura JJ (2000) BiGGER: a new (soft) docking algorithm for predicting protein interactions. Proteins 39: 372-384.
198. Patel P, Harris R, Geddes SM, Strehle EM, Watson JD, Bashir R, Bushby K, Driscoll PC, Keep NH (2008) Solution structure of the inner DysF domain of Myoferlin and implications for limb girdle muscular dystrophy type 2b. J Mol Biol 379: 981-990. S0022-2836(08)00492-0 [pii];10.1016/j.jmb.2008.04.046 [doi].
199. Pereg Y, Lam S, Teunisse A, Biton S, Meulmeester E, Mittelman L, Buscemi G, Okamoto K, Taya Y, Shiloh Y, Jochemsen AG (2006) Differential roles of ATM- and Chk2- mediated phosphorylations of Hdmx in response to DNA damage. Mol Cell Biol 26:
6819-6831.
200. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
201. Piluso G, Politano L, Aurino S, Fanin M, Ricci E, Ventriglia VM, Belsito A, Totaro A, Saccone V, Topaloglu H, Nascimbeni AC, Fulizio L, Broccolini A, Canki-Klain N, Comi LI, Nigro G, Angelini C, Nigro V (2005) Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes. J Med Genet 42: 686-693.
42/9/686 [pii];10.1136/jmg.2004.028738 [doi].
202. Pramono ZA, Lai PS, Tan CL, Takeda S, Yee WC (2006) Identification and characterization of a novel human Dysferlin transcript: Dysferlin_v1. Hum Genet 120:
410-419. 10.1007/s00439-006-0230-1 [doi].
203. Qu J, Liu GH, Wu K, Han P, Wang P, Li J, Zhang X, Chen C (2007) Nitric oxide destabilizes Pias3 and regulates sumoylation. PLoS One 2: e1085.
204. Quach NL, Biressi S, Reichardt LF, Keller C, Rando TA (2009) Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion. Mol Biol Cell 20: 3422-3435. E09-02-0175 [pii];10.1091/mbc.E09-02-0175 [doi].
205. Quach NL, Rando TA (2006) Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells. Dev Biol 293: 38-52.
206. Racchetti G, Lorusso A, Schulte C, Gavello D, Carabelli V, D’Alessandro R, Meldolesi J (2010) Rapid neurite outgrowth in neurosecretory cells and neurons is sustained by the exocytosis of a cytoplasmic organelle, the enlargeosome. J Cell Sci 123: 165-170. jcs.059634 [pii];10.1242/
jcs.059634 [doi].
207. Raghavan S, Bauer C, Mundschau G, Li Q, Fuchs E (2000) Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J Cell Biol 150: 1149-1160.
208. Raghavan S, Vaezi A, Fuchs E (2003) A role for alphabeta1 integrins
in focal adhesion function and polarized cytoskeletal dynamics. Dev Cell 5: 415-427.
S1534580703002612 [pii].
209. Ramakrishnan NA, Drescher MJ, Drescher DG (2009) Direct interaction of otoferlin with syntaxin 1A, SNAP-25, and the L-type voltage-gated calcium channel Cav1.3. J Biol Chem 284: 1364- 1372. M803605200 [pii];10.1074/jbc.
M803605200 [doi].
210. Rawat R, Cohen TV, Ampong B, Francia D, Henriques-Pons A, Hoffman EP, Nagaraju K (2010) Inflammasome up-regulation and activation in Dysferlin- deficient skeletal muscle. Am J Pathol 176: 2891-2900. ajpath.2010.090058 [pii];10.2353/ajpath.2010.090058 [doi].
211. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C, . (1995) Mutations in the proteolytic enzyme calpain 3 cause limb- girdle muscular dystrophy type 2A. Cell 81:
27-40. 0092-8674(95)90368-2 [pii].
212. Richard I, Roudaut C, Marchand S, Baghdiguian S, Herasse M, Stockholm D, Ono Y, Suel L, Bourg N, Sorimachi H, Lefranc G, Fardeau M, Sebille A, Beckmann JS (2000) Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.
J Cell Biol 151: 1583-1590.
213. Rigoutsos I, Floratos A (1998) Combinatorial pattern discovery in biological sequences: The TEIRESIAS algorithm.
Bioinformatics 14: 55-67.
214. Roche JA, Lovering RM, Bloch RJ (2008) Impaired recovery of Dysferlin-null
skeletal muscle after contraction-induced injury in vivo. Neuroreport 19: 1579-1584.
10.1097/WNR.0b013e328311ca35 [doi].
215. Roche JA, Lovering RM, Roche R, Ru LW, Reed PW, Bloch RJ (2010) Extensive mononuclear infiltration and myogenesis characterize recovery of Dysferlin- null skeletal muscle from contraction- induced injuries. Am J Physiol Cell Physiol 298: C298-C312. ajpcell.00122.2009 [pii];10.1152/ajpcell.00122.2009 [doi].
216. Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y, Milan G, Masiero E, del Piccolo P, Foretz M, Scorrano L, Rudolf R, Sandri M (2010) Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 29: 1774-1785.
emboj201060 [pii];10.1038/emboj.2010.60 [doi].
217. Roux I, Safieddine S, Nouvian R, Grati M, Simmler MC, Bahloul A, Perfettini I, Le Gall M, Rostaing P, Hamard G, Triller A, Avan P, Moser T, Petit C (2006) Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 127: 277-289.
S0092-8674(06)01218-9 [pii];10.1016/j.
cell.2006.08.040 [doi].
218. Ruoslahti E (1996) RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715. 10.1146/
annurev.cellbio.12.1.697 [doi].
219. Sakai K, Akanuma H, Imahori K, Kawashima S (1987) A unique specificity of a calcium activated neutral protease indicated in histone hydrolysis. J Biochem 101: 911-918.
220. Salim C, Boxberg YV, Alterio J, Fereol S, Nothias F (2009) The giant protein
AHNAK involved in morphogenesis and laminin substrate adhesion of myelinating Schwann cells. Glia 57: 535-549. 10.1002/
glia.20782 [doi].
221. Sandona D, Betto R (2009) Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med 11: e28.
S1462399409001203 [pii];10.1017/
S1462399409001203 [doi].
222. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR (2010) Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 70:
3780-3790. 0008-5472.CAN-09-4439 [pii];10.1158/0008-5472.CAN-09-4439 [doi].
223. Sherman DL, Brophy PJ (2000) A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J Biol Chem 275: 4537-4540.
224. Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ (2001) Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy.
Neuron 30: 677-687.
225. Shirafuji T, Otsuka Y, Kobessho H, Minami N, Hayashi Y, Nishino I, Kanda F (2008) [Case of LGMD2A (calpainopathy) clinically presenting as Miyoshi distal myopathy]. Rinsho Shinkeigaku 48: 651- 655.
226. Shtivelman E, Bishop JM (1993) The human gene AHNAK encodes a large phosphoprotein located primarily in the nucleus. J Cell Biol 120: 625-630.
227. Shtivelman E, Cohen FE, Bishop JM (1992) A human gene (AHNAK) encoding an
unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci U S A 89: 5472-5476.
228. Shumway SD, Maki M, Miyamoto S (1999) The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J Biol Chem 274: 30874-30881.
229. Sigrist CJ, de Castro E, Langendijk- Genevaux PS, Le Saux V, Bairoch A, Hulo N (2005) ProRule: a new database containing functional and structural information on PROSITE profiles. Bioinformatics 21: 4060- 4066.
230. Skoldberg F, Ronnblom L, Thornemo M, Lindahl A, Bird PI, Rorsman F, Kampe O, Landgren E (2002) Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus. Biochem Biophys Res Commun 291: 951-958. 10.1006/
bbrc.2002.6534 [doi];S0006291X02965344 [pii].
231. Sonnet C, Lafuste P, Arnold L, Brigitte M, Poron F, Authier FJ, Chretien F, Gherardi RK, Chazaud B (2006) Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J Cell Sci 119: 2497-2507. jcs.02988 [pii];10.1242/
jcs.02988 [doi].
232. Sorimachi H, Kinbara K, Kimura S, Takahashi M, Ishiura S, Sasagawa N, Sorimachi N, Shimada H, Tagawa K, Maruyama K (1995) Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem 270: 31158-31162.
233. Sorimachi H, Ono Y, Suzuki K
(2000) Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A. Adv Exp Med Biol 481: 383-395.
234. Sorimachi H, Saido TC, Suzuki K (1994) New era of calpain research.
Discovery of tissue-specific calpains. FEBS Lett 343: 1-5. 0014-5793(94)80595-4 [pii].
235. Sorimachi H, Suzuki K (1992) Sequence comparison among muscle- specific calpain, p94, and calpain subunits.
Biochim Biophys Acta 1160: 55-62.
236. Sorimachi H, Toyama-Sorimachi N, Saido TC, Kawasaki H, Sugita H, Miyasaka M, Arahata K, Ishiura S, Suzuki K (1993) Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem 268: 10593-10605.
237. Spencer MJ, Guyon JR, Sorimachi H, Potts A, Richard I, Herasse M, Chamberlain J, Dalkilic I, Kunkel LM, Beckmann JS (2002) Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation. Proc Natl Acad Sci U S A 99: 8874-8879. 10.1073/pnas.132269299 [doi];132269299 [pii].
238. Stuelsatz P, Pouzoulet F, Lamarre Y, Dargelos E, Poussard S, Leibovitch S, Cottin P, Veschambre P (2010) Down-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblasts. J Biol Chem 285: 12670-12683. M109.063966 [pii];10.1074/jbc.M109.063966 [doi].
239. Sussman J, Stokoe D, Ossina N, Shtivelman E (2001) Protein kinase B phosphorylates AHNAK and regulates its
subcellular localization. J Cell Biol 154:
1019-1030. 10.1083/jcb.200105121 [doi];154/5/1019 [pii].
240. Tagawa K, Taya C, Hayashi Y, Nakagawa M, Ono Y, Fukuda R, Karasuyama H, Toyama-Sorimachi N, Katsui Y, Hata S, Ishiura S, Nonaka I, Seyama Y, Arahata K, Yonekawa H, Sorimachi H, Suzuki K (2000) Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A. Hum Mol Genet 9: 1393- 1402. ddd144 [pii].
241. Talavera G, Castresana J (2007) Improvement of phylogenies after removing divergent and ambiguously aligned blocks from protein sequence alignments.
Syst Biol 56: 564-577. 780704285 [pii];10.1080/10635150701472164 [doi].
242. Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, Richard I (2003) Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol 23: 9127-9135.
243. Therrien C, di Fulvio S, Pickles S, Sinnreich M (2009) Characterization of lipid binding specificities of Dysferlin C2 domains reveals novel interactions with phosphoinositides. Biochemistry 48: 2377- 2384. 10.1021/bi802242r [doi].
244. Therrien C, Dodig D, Karpati G, Sinnreich M (2006) Mutation impact on Dysferlin inferred from database analysis and computer-based structural predictions. J Neurol Sci 250: 71-78.
S0022-510X(06)00331-5 [pii];10.1016/j.
jns.2006.07.004 [doi].
245. Thomas-Ecker S, Lindecke A, Hatzmann W, Kaltschmidt C, Zanker KS, Dittmar T (2007) Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells. Proc Natl Acad Sci U S A 104: 5539-5544. 0700732104 [pii];10.1073/pnas.0700732104 [doi].
246. Tomczak KK, Marinescu VD, Ramoni MF, Sanoudou D, Montanaro F, Han M, Kunkel LM, Kohane IS, Beggs AH (2004) Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J 18: 403-405. 10.1096/fj.03-0568fje [doi];03-0568fje [pii].
247. Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilagyi A, Banoczi Z, Hudecz F, Friedrich P (2004) On the sequential determinants of calpain cleavage. J Biol Chem 279: 20775-20785.
248. van Haagen HH, ‘t Hoen PA, Botelho Bovo A, de Morree A, van Mulligen EM, Chichester C, Kors JA, den Dunnen JT, van Ommen GJ, van der Maarel SM, Kern VM, Mons B, Schuemie MJ (2009) Novel protein-protein interactions inferred from literature context. PLoS One 4: e7894.
10.1371/journal.pone.0007894 [doi].
249. Vernon-Wilson EF, Aurade F, Brown SB (2006) CD31 promotes beta1 integrin- dependent engulfment of apoptotic Jurkat T lymphocytes opsonized for phagocytosis by fibronectin. J Leukoc Biol 79: 1260-1267.
jlb.1005571 [pii];10.1189/jlb.1005571 [doi].
250. Vertegaal AC, Ogg SC, Jaffray E, Rodriguez MS, Hay RT, Andersen JS, Mann M, Lamond AI (2004) A proteomic study of SUMO-2 target proteins. J Biol Chem 279:
33791-33798.
251. Walter MC, Braun C, Vorgerd M, Poppe M, Thirion C, Schmidt C, Schreiber H, Knirsch UI, Brummer D, Muller-Felber W, Pongratz D, Muller-Hocker J, Huebner A, Lochmuller H (2003) Variable reduction of caveolin-3 in patients with LGMD2B/MM. J Neurol 250: 1431-1438. 10.1007/s00415- 003-0234-x [doi].
252. Warren GL, Hulderman T, Mishra D, Gao X, Millecchia L, O’Farrell L, Kuziel WA, Simeonova PP (2005) Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J 19: 413-415. 04- 2421fje [pii];10.1096/fj.04-2421fje [doi].
253. Washington NL, Ward S (2006) FER-1 regulates Ca2+ -mediated membrane fusion during C. elegans spermatogenesis.
J Cell Sci 119: 2552-2562. jcs.02980 [pii];10.1242/jcs.02980 [doi].
254. Weerasinghe D, McHugh KP, Ross FP, Brown EJ, Gisler RH, Imhof BA (1998) A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol 142: 595-607.
255. Weiler T, Bashir R, Anderson LV, Davison K, Moss JA, Britton S, Nylen E, Keers S, Vafiadaki E, Greenberg CR, Bushby CR, Wrogemann K (1999) Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 8:
871-877. ddc107 [pii].
256. Wein N, Krahn M, Courrier S, Bartoli M, Salort-Campana E, Nguyen K, Fernandez C, Pouget J, Fossat C, Depetris D, Leturcq F, Cau P, Levy N (2010) Immunolabelling and flow cytometry as new tools to explore Dysferlinopathies. Neuromuscul Disord 20: 57-60. S0960-8966(09)00584-7
[pii];10.1016/j.nmd.2009.08.004 [doi].
257. Welm AL, Timchenko NA, Ono Y, Sorimachi H, Radomska HS, Tenen DG, Lekstrom-Himes J, Darlington GJ (2002) C/EBPalpha is required for proteolytic cleavage of cyclin A by calpain 3 in myeloid precursor cells. J Biol Chem 277:
33848-33856. 10.1074/jbc.M204096200 [doi];M204096200 [pii].
258. Wenzel K, Carl M, Perrot A, Zabojszcza J, Assadi M, Ebeling M, Geier C, Robinson PN, Kress W, Osterziel KJ, Spuler S (2006) Novel sequence variants in Dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2- domain misfolding. Hum Mutat 27: 599- 600. 10.1002/humu.9424 [doi].
259. Williams S, Mustoe T, Mulcahy T, Griffiths M, Simpson D, Antoniou M, Irvine A, Mountain A, Crombie R (2005) CpG- island fragments from the HNRPA2B1/
CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol 5: 17. 1472-6750-5- 17 [pii];10.1186/1472-6750-5-17 [doi].
260. Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR, van KC (2006) IL-
10-producing macrophages preferentially clear early apoptotic cells. Blood 107:
4930-4937. 2005-10-4144 [pii];10.1182/
blood-2005-10-4144 [doi].
261. Yamaji S, Suzuki A, Kanamori H, Mishima W, Yoshimi R, Takasaki H, Takabayashi M, Fujimaki K, Fujisawa S, Ohno S, Ishigatsubo Y (2004) Affixin interacts with alpha-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell-substrate interaction. J Cell Biol 165: 539-551. 10.1083/jcb.200308141 [doi];jcb.200308141 [pii].
262. Yasunaga S, Grati M, Chardenoux S, Smith TN, Friedman TB, Lalwani AK, Wilcox ER, Petit C (2000) OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9. Am J Hum Genet 67: 591-600. S0002-9297(07)63246-7 [pii];10.1086/303049 [doi].
263. Yasunaga S, Grati M, Cohen-Salmon M, El-Amraoui A, Mustapha M, Salem N, El- Zir E, Loiselet J, Petit C (1999) A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 21: 363-369.
10.1038/7693 [doi].
